LANGaware, a pioneering AI-driven healthcare technology company, has entered into a strategic partnership with Bioiatriki Healthcare Group, one of Southeast Europe’s largest private healthcare providers. This collaboration aims to advance the early detection and management of neurodegenerative conditions, such as Alzheimer’s Disease and Mild Cognitive Impairment (MCI), in Greece and Cyprus.
Key Features of the Partnership:
- Integration of Advanced AI Platform:
- Bioiatriki will integrate LANGaware’s AI-driven platform into its network of over 75 diagnostic centers.
- AI Analysis of Digital Biomarkers:
- The platform analyzes voice and speech digital biomarkers, enabling early detection of cognitive and behavioral health conditions with unmatched accuracy.
- Patient Empowerment:
- This technology allows patients to detect dementia symptoms at their earliest stages, significantly enhancing patient outcomes and quality of life.
Statements from Leadership:
- Dr. Vassiliki Rentoumi, Founder and CEO of LANGaware:
- “We are excited to collaborate with Bioiatriki Healthcare Group to bring our innovative technology to more patients. This partnership aligns with our mission to revolutionize early diagnosis and provide effective, accessible solutions for cognitive health management globally.”
Performance Metrics of LANGaware’s Platform:
- Rapid and Accurate Results:
- Results are provided within minutes, requiring only a brief voice recording of the participant describing an image or daily activity.
- High Sensitivity and Specificity:
- The system boasts a sensitivity of 90% and specificity of 85% in detecting Alzheimer’s Disease and MCI, significantly reducing the risk of misdiagnosis and unnecessary treatments.
Expected Outcomes of the Integration:
- Improved Patient Outcomes:
- The integration is expected to enhance healthcare efficiency by enabling timely interventions and personalized support.
- Expansion of Advanced Diagnostic Services:
- This partnership marks a significant step forward in expanding access to advanced diagnostic services and represents a shared commitment to improving cognitive health management.
By leveraging AI technology, LANGaware is revolutionizing cognitive and behavioral health screening. The integration of its advanced technology within Bioiatriki’s healthcare services enables early, accurate, and objective detection of conditions, ultimately reducing healthcare burdens and improving overall well-being.
